426 related articles for article (PubMed ID: 15894301)
1. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients.
González C; García-Berrocal B; Pérez M; Navajo JA; Herraez O; González-Buitrago JM
Clin Chim Acta; 2005 Sep; 359(1-2):109-14. PubMed ID: 15894301
[TBL] [Abstract][Full Text] [Related]
2. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
Vos PA; Bast EJ; Derksen RH
Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different test systems for simultaneous autoantibody detection in connective tissue diseases.
Eissfeller P; Sticherling M; Scholz D; Hennig K; Lüttich T; Motz M; Kromminga A
Ann N Y Acad Sci; 2005 Jun; 1050():327-39. PubMed ID: 16014549
[TBL] [Abstract][Full Text] [Related]
4. Validation of a new screening strategy for anti-extractable nuclear antigen antibodies.
Van Praet JT; Vander Cruyssen B; Bonroy C; Smith V; Delanghe J; De Keyser F
Clin Exp Rheumatol; 2009; 27(6):971-6. PubMed ID: 20149314
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the BioPlex 2200 ANA screen for the detection of antinuclear antibodies and comparison with conventional methods.
Desplat-Jego S; Bardin N; Larida B; Sanmarco M
Ann N Y Acad Sci; 2007 Aug; 1109():245-55. PubMed ID: 17785313
[TBL] [Abstract][Full Text] [Related]
6. Ineffectiveness of rat liver tissues in the screening of connective tissue disease.
Aziz KA
Saudi Med J; 2004 Apr; 25(4):442-6. PubMed ID: 15083212
[TBL] [Abstract][Full Text] [Related]
7. [Detection of anti-SSA/Ro antibody by ELISA, double immunodiffusion, and immunoblotting: a comparative study].
Tong SQ; Shi Q; Wen XH; Gan XD; Shi YP; Zhao Y; Zeng XF; Zhang FC; Dong Y
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2455-7. PubMed ID: 17156670
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
[TBL] [Abstract][Full Text] [Related]
9. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods.
Homburger HA; Cahen YD; Griffiths J; Jacob GL
Arch Pathol Lab Med; 1998 Nov; 122(11):993-9. PubMed ID: 9822128
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies.
Shovman O; Gilburd B; Barzilai O; Shinar E; Larida B; Zandman-Goddard G; Binder SR; Shoenfeld Y
Ann N Y Acad Sci; 2005 Jun; 1050():380-8. PubMed ID: 16014555
[TBL] [Abstract][Full Text] [Related]
11. Detection of anti-nuclear antibodies from filter paper blood clots using indirect immunoenzyme technique: preliminary experience and results.
Chopra A; Anuradha V; Edmonds J
J Assoc Physicians India; 2000 May; 48(5):493-6. PubMed ID: 11273141
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of indirect immunofluorescence and enzyme immunoassay methods for the determination of antinuclear antibodies].
Yilmaz O; Karaman M; Ergon MC; Bahar IH; Yuluğ N
Mikrobiyol Bul; 2004; 38(1-2):85-90. PubMed ID: 15293906
[TBL] [Abstract][Full Text] [Related]
13. Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population.
Sharmin S; Ahmed S; Abu Saleh A; Rahman F; Choudhury MR; Hassan MM
Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):74-8. PubMed ID: 26415344
[TBL] [Abstract][Full Text] [Related]
14. [Detection of anti-ENA autoantibodies in patients with systemic connective tissue diseases. Analytical variability and diagnostic sensitivity of 4 methods].
Villalta D; Bizzaro N; Tonutti E; Visentin D; Manoni F; Piazza A; Toffolo L; Rizzotti P; Clemen P; Pradella M; Bassetti D; Tozzoli R
Recenti Prog Med; 1999 Nov; 90(11):579-84. PubMed ID: 10608146
[TBL] [Abstract][Full Text] [Related]
15. The clinical significance of antinuclear antibodies in connective tissue disease.
Pahor A; Krajnc I; Gorenjak M; Holc I
Wien Klin Wochenschr; 1998 May; 110(9):338-41. PubMed ID: 9629626
[TBL] [Abstract][Full Text] [Related]
16. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay.
Op De Beeck K; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
Autoimmun Rev; 2011 Oct; 10(12):801-8. PubMed ID: 21741497
[TBL] [Abstract][Full Text] [Related]
17. Performance of antinuclear antibody connective tissue disease screen.
López-Hoyos M; Rodríguez-Valverde V; Martinez-Taboada V
Ann N Y Acad Sci; 2007 Aug; 1109():322-9. PubMed ID: 17785321
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of anti-ribosomal P protein immunoassay in Japanese patients with connective tissue diseases: comparison with an indirect immunofluorescence assay.
Muro Y; Sugiura K; Morita Y; Tomita Y
Scand J Rheumatol; 2009; 38(6):460-3. PubMed ID: 19922022
[TBL] [Abstract][Full Text] [Related]
19. [Performance and clinical evaluation of antinuclear antibody test based on fluorescence enzyme immunoassay].
Watanabe N; Nagatomo R; Okubo S; Yokota H; Ikeda H; Yatomi Y
Rinsho Byori; 2014 Apr; 62(4):315-23. PubMed ID: 25022060
[TBL] [Abstract][Full Text] [Related]
20. [Comparison between line immunoassay (LIA) and enzyme-linked immunosorbent assay (ELISA) for the determination of antibodies to extractable nuclear antigenes (ENA) with reference to other laboratory results and clinical features].
Maclachlan D; Vogt P; Wu X; Rose L; Tyndall A; Hasler P
Z Rheumatol; 2002 Oct; 61(5):534-44. PubMed ID: 12399881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
